Interactions between the FTO and GNB3 Genes Contribute to Varied Clinical Phenotypes in Hypertension

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Kumar, Rahul ^a,c   Kohli, Samantha ^a   Alam, Perwez ^a   Barkotoky, Ritankur ^b   Gupta, Mohit ^b   Tyagi, Sanjay ^b   Jain, S K ^c   Pasha, M A Qadar ^a  

^a NATIONAL CHEMICAL LABORATORY   (India)

^b G B PANT HOSPITAL   (India)

^c HAMDARD UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; ARTICLE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; FEMALE; FTO GENE; GENE; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; GNB3 GENE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MULTIFACTOR DIMENSIONALITY REDUCTION; PATHOPHYSIOLOGY; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

ALLELES; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; EPISTASIS, GENETIC; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; TRANSCRIPTION FACTORS;

EID: 84877728506     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063934     Document Type: Article

References (48)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, et al. (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365: 217-223.
2. Joyner MJ, Charkoudian N, Wallin BG, (2008) A sympathetic view of the sympathetic nervous system and human blood pressure regulation. Exp Physiol 93: 715-724.
3. Xia H, Suda S, Bindom S, Feng Y, Gurley SB, et al. (2011) ACE2-Mediated reduction of oxidative stress in the central nervous system is associated with improvement of autonomic function. PLoS One 6: e22682.
4. Guyenet PG, (2006) The sympathetic control of blood pressure. Nat Rev Neurosci 7: 335-346.
5. Bunnett NW, Cottrell GS, (2010) Trafficking and signaling of G protein-coupled receptors in the nervous system: implications for disease and therapy. CNS Neurol Disord Drug Targets 9: 539-556.
6. Zolk O, Kouchi I, Schnabel P, Bohm M, (2000) Heterotrimeric G proteins in heart disease. Can J Physiol Pharmacol 78: 187-198.
7. Mitchell BD, Kammerer CM, Blangero J, Mahaney MC, Rainwater DL, et al. (1996) Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. The San Antonio Family Heart Study. Circulation 94: 2159-2170.
8. Hong Y, de FU, Heller DA, McClearn GE, Pedersen N, (1994) Genetic and environmental influences on blood pressure in elderly twins. Hypertension 24: 663-670.
9. Harrap SB, Stebbing M, Hopper JL, Hoang HN, Giles GG, (2000) Familial patterns of covariation for cardiovascular risk factors in adults: The victorian family heart study. Am J Epidemiol 152: 704-715.
10. Yang J, Loos RJ, Powell JE, Medland SE, Speliotes EK, et al. (2012) FTO genotype is associated with phenotypic variability of body mass index. Nature 490: 267-272.
11. Fall T, Ingelsson E (2012) Genome-wide association studies of obesity and metabolic syndrome. Mol Cell Endocrinol. S0303-7207(12)00413-3.
12. Peng S, Zhu Y, Xu F, Ren X, Li X, et al. (2011) FTO gene polymorphisms and obesity risk: a meta-analysis. BMC Med 9: 71.
13. Niu W, Qi Y, (2011) Association of alpha-adducin and G-protein beta3 genetic polymorphisms with hypertension: a meta-analysis of Chinese populations. PLoS One 6: e17052.
14. Wen W, Cho YS, Zheng W, Dorajoo R, Kato N, et al. (2012) Meta-analysis identifies common variants associated with body mass index in east Asians. Nat Genet 44: 307-311.
15. Pemberton TJ, Mehta NU, Witonsky D, Di RA, Allayee H, et al. (2008) Prevalence of common disease-associated variants in Asian Indians. BMC Genet 9: 13.
16. Gerken T, Girard CA, Tung YC, Webby CJ, Saudek V, et al. (2007) The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 318: 1469-1472.
17. Hamet P, Merlo E, Seda O, Broeckel U, Tremblay J, et al. (2005) Quantitative founder-effect analysis of French Canadian families identifies specific loci contributing to metabolic phenotypes of hypertension. Am J Hum Genet 76: 815-832.
18. Pausova Z, Syme C, Abrahamowicz M, Xiao Y, Leonard GT, et al. (2009) A common variant of the FTO gene is associated with not only increased adiposity but also elevated blood pressure in French Canadians. Circ Cardiovasc Genet 2: 260-269.
19. Neves SR, Ram PT, Iyengar R, (2002) G protein pathways. Science 296: 1636-1639.
20. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, et al. (1998) Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet 18: 45-48.
21. Siffert W, (2003) G-protein beta3 subunit 825T allele and hypertension. Curr Hypertens Rep 5: 47-53.
22. Bagos PG, Elefsinioti AL, Nikolopoulos GK, Hamodrakas SJ, (2007) The GNB3 C825T polymorphism and essential hypertension: a meta-analysis of 34 studies including 14,094 cases and 17,760 controls. J Hypertens 25: 487-500.
23. Timpson NJ, Harbord R, Davey SG, Zacho J, Tybjaerg-Hansen A, et al. (2009) Does greater adiposity increase blood pressure and hypertension risk?: Mendelian randomization using the FTO/MC4R genotype. Hypertension 54: 84-90.
24. Chang YC, Liu PH, Lee WJ, Chang TJ, Jiang YD, et al. (2008) Common variation in the fat mass and obesity-associated (FTO) gene confers risk of obesity and modulates BMI in the Chinese population. Diabetes 57: 2245-2252.
25. Souza RP, De LV, Muscettola G, Rosa DV, de BA, et al. (2008) Association of antipsychotic induced weight gain and body mass index with GNB3 gene: a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 32: 1848-1853.
26. Klenke S, Kussmann M, Siffert W, (2011) The GNB3 C825T polymorphism as a pharmacogenetic marker in the treatment of hypertension, obesity, and depression. Pharmacogenet Genomics 21: 594-606.
27. Stephens M, Smith NJ, Donnelly P, (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68: 978-989.
28. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
29. Hahn LW, Ritchie MD, Moore JH, (2003) Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 19: 376-382.
30. Potter MA, De Jong KA, (2000) Cooperative coevolution: an architecture for evolving coadapted subcomponents. Evol Comput 8: 1-29.
31. Ahmad T, Chasman DI, Mora S, Pare G, Cook NR, et al. (2010) The fat-mass and obesity-associated (FTO) gene, physical activity, and risk of incident cardiovascular events in white women. Am Heart J 160: 1163-1169.
32. Sentinelli F, Incani M, Coccia F, Capoccia D, Cambuli VM, et al. (2012) Association of FTO polymorphisms with early age of obesity in obese Italian subjects. Exp Diabetes Res. 2012: 872176.
33. Nejatizadeh A, Kumar R, Stobdan T, Qadar Pasha MA, (2011) Association of GNB3 C825T polymorphism with plasma electrolyte balance and susceptibility to hypertension. Genet Mol Biol 34: 553-556.
34. Wenzel RR, Siffert W, Bruck H, Philipp T, Schafers RF, (2002) Enhanced vasoconstriction to endothelin-1, angiotensin II and noradrenaline in carriers of the GNB3 825T allele in the skin microcirculation. Pharmacogenetics 12: 489-495.
35. Kelly TN, Rice TK, Gu D, Hixson JE, Chen J, et al. (2009) Novel genetic variants in the alpha-adducin and guanine nucleotide binding protein beta-polypeptide 3 genes and salt sensitivity of blood pressure. Am J Hypertens 22: 985-992.
36. Cordell HJ, (2009) Detecting gene-gene interactions that underlie human diseases. Nat Rev Genet 10: 392-404.
37. Moore JH, (2003) The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum Hered 56: 73-82.
38. Dina C, Meyre D, Gallina S, Durand E, Korner A, et al. (2007) Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet 39: 724-726.
39. Mamun AA, Lawlor DA, O'Callaghan MJ, Williams GM, Najman JM, (2005) Effect of body mass index changes between ages 5 and 14 on blood pressure at age 14: findings from a birth cohort study. Hypertension 45: 1083-1087.
40. Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM, (2003) Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 42: 878-884.
41. Jones DW, (1996) Body weight and blood pressure. Effects of weight reduction on hypertension. Am J Hypertens 9: 50s-54s.
42. Rana BK, Insel PA, Payne SH, Abel K, Beutler E, et al. (2007) Population-based sample reveals gene-gender interactions in blood pressure in White Americans. Hypertension 49: 96-106.
43. Zhao Q, Wang L, Yang W, Chen S, Huang J, et al. (2008) Interactions among genetic variants from contractile pathway of vascular smooth muscle cell in essential hypertension susceptibility of Chinese Han population. Pharmacogenet Genomics 18: 459-466.
44. Bae Y, Park C, Han J, Hong YJ, Song HH, et al. (2007) Interaction between GNB3 C825T and ACE I/D polymorphisms in essential hypertension in Koreans. J Hum Hypertens 21: 159-166.
45. Newton-Cheh C, Hirschhorn JN, (2005) Genetic association studies of complex traits: design and analysis issues. Mutat Res 573: 54-69.
46. Ameur A, Rada-Iglesias A, Komorowski J, Wadelius C, (2009) Identification of candidate regulatory SNPs by combination of transcription-factor-binding site prediction, SNP genotyping and haploChIP. Nucleic Acids Res 37: e85.
47. Vaquerizas JM, Kummerfeld SK, Teichmann SA, Luscombe NM, (2009) A census of human transcription factors: function, expression and evolution. Nat Rev Genet 10: 252-263.
48. Indian Genome Variation Consortium, (2008) Genetic landscape of the people of India: a canvas for disease gene exploration. J Genet 87: 3-20.